Youngsoo Kim Selected Research

2- methyl- 2- (2- methylpropenyl)- 2,3- dihydronaphtho(2,3- b)furan- 4,9- dione

10/2005

Suppressive effects of furonaphthoquinone NFD-37 on the production of lipopolysaccharide-inducible inflammatory mediators in macrophages RAW 264.7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youngsoo Kim Research Topics

Disease

71	Neoplasms (Cancer) 01/2022 - 02/2002
20	Experimental Melanoma 01/2018 - 12/2004
17	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 12/2006
15	Inflammation (Inflammations) 01/2021 - 03/2008
11	Hyperpigmentation 01/2020 - 05/2002
11	Melanoma (Melanoma, Malignant) 01/2020 - 05/2002
7	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2006
7	Breast Neoplasms (Breast Cancer) 10/2020 - 10/2008
7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 07/2002
6	Lung Neoplasms (Lung Cancer) 11/2015 - 12/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2010
5	Adenocarcinoma 03/2021 - 12/2014
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016 - 03/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 10/2005
5	Leukemia 09/2012 - 03/2002
4	Liver Neoplasms (Liver Cancer) 05/2021 - 08/2018
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2012
4	Melanosis (Freckles) 01/2018 - 12/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 01/2012
4	Arthritis (Polyarthritis) 11/2015 - 05/2008
4	Type 2 Diabetes Mellitus (MODY) 04/2012 - 11/2007
4	Edema (Dropsy) 01/2010 - 05/2003
3	Pancreatic Cyst 08/2020 - 10/2017
3	Carcinoma (Carcinomatosis) 04/2020 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2017
3	Lymphoma (Lymphomas) 11/2018 - 01/2015
3	Sepsis (Septicemia) 01/2018 - 02/2015
3	Neoplasms, Cystic, Mucinous, and Serous 01/2018 - 01/2016
3	Lentigo (Lentiginosis) 02/2011 - 12/2004
3	Carcinogenesis 09/2010 - 10/2008
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2002 - 02/2002
2	Dementia (Dementias) 01/2022 - 01/2018
2	Ischemic Stroke 11/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2017
2	Amyloid Plaque 11/2019 - 11/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 03/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2018 - 01/2017
2	Triple Negative Breast Neoplasms 01/2018 - 01/2017
2	Acute Liver Failure (Fulminant Hepatic Failure) 11/2017 - 01/2017
2	Infections 01/2017 - 03/2012

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
21	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
17	Melanins (Melanin)IBA 01/2020 - 02/2006
16	Antisense OligonucleotidesIBA 05/2021 - 12/2006
14	CytokinesIBA 01/2018 - 11/2007
13	ProteomeIBA 05/2020 - 11/2007
11	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019 - 01/2011
9	NF-kappa B (NF-kB)IBA 01/2013 - 04/2008
8	alpha-MSHIBA 08/2010 - 12/2004
7	Pharmaceutical PreparationsIBA 01/2022 - 08/2006
6	Messenger RNA (mRNA)IBA 05/2021 - 02/2006
6	Monophenol Monooxygenase (Tyrosinase)IBA 11/2011 - 05/2002
5	Long Noncoding RNAIBA 03/2021 - 02/2013
5	Biological ProductsIBA 01/2021 - 01/2017
5	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 04/2015
5	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 10/2005
4	LigandsIBA 01/2022 - 06/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2006
4	LipopolysaccharidesIBA 01/2017 - 01/2012
4	Skin Lightening PreparationsIBA 01/2017 - 05/2002
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 01/2013
4	Histone Deacetylase InhibitorsIBA 01/2015 - 07/2007
4	Vorinostat FDA Link 01/2015 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 12/2012 - 09/2008
4	ResveratrolIBA 10/2011 - 08/2003
4	CarrageenanIBA 01/2010 - 05/2003
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2006
3	EnzymesIBA 01/2021 - 02/2006
3	Sorafenib (BAY 43-9006)FDA Link 12/2018 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 12/2018 - 04/2015
3	AndrogensIBA 10/2018 - 09/2008
3	Peptides (Polypeptides)IBA 08/2018 - 11/2010
3	acarboxyprothrombin (PIVKA)IBA 07/2018 - 01/2017
3	GraphiteIBA 01/2017 - 11/2013
3	Small Interfering RNA (siRNA)IBA 04/2016 - 11/2012
3	AntioxidantsIBA 10/2014 - 09/2010
3	CaspasesIBA 09/2012 - 03/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2022 - 01/2021
2	Fetal Proteins (Fetoprotein)IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2013
2	Phosphotransferases (Kinase)IBA 10/2020 - 01/2017
2	AutoantibodiesIBA 01/2020 - 01/2017
2	Stem Cell FactorIBA 01/2020 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 09/2012
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2019 - 09/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2017
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 05/2013
2	AcidsIBA 01/2019 - 08/2010
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2018 - 12/2006
2	danvatirsenIBA 11/2018 - 11/2015
2	Vitamin K FDA Link 07/2018 - 04/2017
2	Prothrombin (Factor II)IBA 07/2018 - 04/2017
2	Interleukin-4 (Interleukin 4)IBA 01/2017 - 04/2016
2	caffeic acidIBA 01/2017 - 01/2017

Therapy/Procedure

25	Therapeutics 10/2020 - 02/2002
9	Immunotherapy 01/2022 - 07/2010
6	Drug Therapy (Chemotherapy) 05/2021 - 03/2003
4	Castration 01/2019 - 04/2015
2	Electrodes (Electrode) 10/2020 - 11/2013
2	Ligation 01/2017 - 03/2002